Medicamen Biotech Limited Insider Trading Disclosure

Summary of Key Information

  • BSE Scrip Code: 531146
  • NSE Trading Symbol: MEDICAMEQ
  • Date of Disclosure: 30.09.2026
  • Insider: Mr. Sanjay Bansal
  • Designation: Director
  • Immediate Relative Involved: Not applicable
  • Trading Window: Not specified in document
  • Nature of Transaction:

o Type: Sale of Equity Shares

o Quantity: 32,813 Equity Shares

o Mode: On market transaction

Detailed Transaction Information

Insider Details:

  • Name: Sanjay Bansal S/o Late Mr. Kedar Nath
  • PAN: AELPB1342K
  • Address: House No. 5, First Floor, Road No.-65, Punjabi Bagh West, New Delhi-110026
  • Contact No.: +919810061262
  • Category: Director

Holding Prior to Transaction:

  • Type of security: Equity shares
  • Quantity: 1,02,813 Equity Shares
  • Percentage holding: 0.76%

Transaction Details:

  • Type of security: Equity Shares
  • Quantity disposed: 32,813 Equity Shares
  • Transaction value: ₹1,05,42,440 (One Crore Five Lakhs Forty-Two Thousand Four Hundred and Forty)
  • Transaction type: Sale
  • Transaction period: From 28.09.2026 to 30.09.2026
  • Mode of disposal: On market

Holding Post Transaction:

  • Type of security: Equity Shares
  • Quantity: 70,000 Equity Shares
  • Percentage holding: 0.51%

Regulatory Compliance:

  • Disclosure made pursuant to Regulation 7(2)(b) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Date of intimation to company: 30.09.2026
  • Form C submitted for continual disclosure requirements

Derivative Trading:

  • No derivative trading activity reported
  • All fields marked as "NA" for derivative contracts

Company Information:

  • Registered & Corporate Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019
  • CIN No.: L74899DL1993PLC056594
  • Company Secretary & Compliance Officer: Parul Choudhary (ACS: 44157)
  • Director: Sanjay Bansal (DIN: 00121667)